Supply deal with neurosurgery device firm renewed by Stryker | Intelligent Implant closes financing round | Report: Worldwide market for bioabsorbable scaffolds set for growth
July 24, 2015
ADVAMED SmartBrief
News for medical technology professionals

Top Story
Supply deal with neurosurgery device firm renewed by Stryker
Stryker has reupped its contract with Synergetics, a neurosurgical and opthalmic device firm based in O'Fallon, Mo. The deal, extended until March 2019, calls for Synergetics to deliver consumables such as disposable aspirator instrument tips to be used with the ultrasonic aspirator console and hand pieces from Stryker. (Boston) (7/23)
Share: LinkedInTwitterFacebookGoogle+Email
Crafting Your Company's Story
Call it an elevator pitch or your company's story. However you describe it, being able to quickly summarize your business can help you engage with customers, partners and investors. Click here to read Boomtown: Think Like a Startup

Business & Market Trends
Intelligent Implant closes financing round
Intelligent Implant Systems has closed a funding round with Yadkin Small Business Lending. The proceeds will be used to advance the company's Revolution Spinal System, an implant that can connect bone screws while adjusting for angulation and distance between them. (7/23)
Share: LinkedInTwitterFacebookGoogle+Email
Report: Worldwide market for bioabsorbable scaffolds set for growth
A GlobalData report predicts the global market for bioabsorbable scaffolds will reach $2.1 billion by 2021, with a 42.1% compound annual growth rate. New product approvals are driving the market, which was valued at $143.7 million last year. (7/23)
Share: LinkedInTwitterFacebookGoogle+Email
Cardiovascular segment drives Q2 profit growth for Boston Scientific
Boston Scientific generated $102 million in profit in the second quarter, up from $4 million generated in the same period last year. The growth was driven by the company's cardiovascular division. MarketWatch (7/23)
Share: LinkedInTwitterFacebookGoogle+Email
Science & Health
Trial begins in China for Micell's coronary stent
A planned 428-patient, multisite study has been launched by Micell Technologies in China to assess its MiStent SES, a sirolimus-eluting stent designed to treat coronary artery disease. The Durham, N.C., firm will compare the device with the Tivoli stent from Essen Technologies. FDAnews (7/24)
Share: LinkedInTwitterFacebookGoogle+Email
Emerging Technologies
FDA expands clearance for Propeller Health platform
The digital health platform from Propeller Health has received a second 510(k) clearance from the FDA. The product is now cleared for use with the dry powder inhaler Diskus and medications developed by GlaxoSmithKline for chronic obstructive pulmonary disease as well as asthma. The platform monitors inhaler use, analyzes the data and provides a report for COPD and asthma patients. It is already cleared for Respimat, an inhaler from Boehringer Ingelheim designed to treat COPD. FDAnews (7/24)
Share: LinkedInTwitterFacebookGoogle+Email
EU OKs endomicroscopic navigation platform from Mauna Kea
The Cellvizio 800, a near-infrared system developed by Mauna Kea for endomicroscopic navigation during various surgical procedures, obtained CE mark approval from European regulators. The Paris-based firm said the product can now be used in urinary, pulmonary and gastroenterology treatments. (Boston) (7/23)
Share: LinkedInTwitterFacebookGoogle+Email
Government & Regulatory
FDA clears transoral surgery system from Medrobotics
The Flex system, a robotic transoral surgery device from Medrobotics, has received 510(k) clearance from the FDA and is now available in the U.S. The Raynham, Mass.-based firm said the device visualizes and accesses the throat and mouth using high-definition vision technology, flexible instruments and a flexible robotic endoscope. The system is already available in Europe. (Boston) (7/23)
Share: LinkedInTwitterFacebookGoogle+Email
Vertebral body replacement from Oxford Performance is cleared by FDA
The FDA has granted 510(k) clearance to Oxford Performance Materials for its SpineFab, a vertebral body replacement device. The system is designed to replace unstable, damaged or collapsed vertebral body caused by trauma or tumor. (7/23)
Share: LinkedInTwitterFacebookGoogle+Email
Medical Technology Learning Institute
IDE Submissions Workshop
Oct. 21 | Washington, D.C.
During this interactive workshop, FDA staff leaders (invited) and industry experts will lead professionals through the regulatory and practical guidelines governing when an investigational device exemption (IDE) is required. Topics to be discussed include the components of a successful submission, common errors, the ins and outs of BIMO inspections and more. Learn more.
Share: LinkedInTwitterFacebookGoogle+Email
Join the AdvaMed-MTLI LinkedIn group or follow them on Twitter!
Build close relationships with member companies, both small and large, and receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Interact in discussions that leverage the leadership and expertise of the medical technology industry. This social group is full of key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Aside from practical learning opportunities, this LinkedIn group provides the premier opportunity to network with key players from virtually every aspect of the industry. Link to the AdvaMed MTLI LinkedIn group page.  Link to the AdvaMed MTLI Twitter account.
Share: LinkedInTwitterFacebookGoogle+Email
powered by
Legal Counsel II FDA
MEDTRONIC, INC. - Washington, DC
There is no passion to be found playing small -- in settling for a life that is less than the one you are capable of living."
-- Nelson Mandela,
political activist and president of South Africa
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Lisa Gough
Advertising:  Meryl Harold
  P: 202.407.7828
Jobs Contact:

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information